Profile data is unavailable for this security.
About the company
Fuji Pharma Co., Ltd. is a Japan-based company mainly engaged in the manufacture and sale of medical products. The Company is engaged in the manufacture and sale of hormone medicines for obstetrics and gynecology department, as well as injectable drugs for radiological department such as radiopaque dye for urinary tracts and blood vessels through its branches. In addition, the Company purchases its main pharmaceutical ingredients from its main parent company.
- Revenue in JPY (TTM)46.14bn
- Net income in JPY6.15bn
- Incorporated1965
- Employees1.62k
- LocationFuji Pharma Co Ltd6FIzumidate Bujin Tori, 5-7, Samban-choCHIYODA-KU 102-0075JapanJPN
- Phone+81 335563344
- Fax+81 335564455
- Websitehttps://www.fujipharma.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TAIKO PHARMACEUTICAL CO LTD | 6.28bn | -2.34bn | 18.38bn | 208.00 | -- | 2.26 | -- | 2.93 | -46.93 | -46.93 | 125.40 | 160.66 | 0.434 | 1.69 | 2.94 | 30,201,920.00 | -16.12 | -- | -19.68 | -- | 55.73 | -- | -37.15 | -- | 2.83 | -- | 0.2166 | -- | 21.43 | -- | 26.23 | -- | -- | -- |
| CellSeed Inc | 199.47m | -957.04m | 19.58bn | 35.00 | -- | 8.93 | -- | 98.16 | -30.72 | -30.72 | 6.40 | 63.29 | 0.0892 | 1.65 | 7.91 | 5,699,172.00 | -42.79 | -49.69 | -46.02 | -54.55 | 55.38 | 63.66 | -479.79 | -428.62 | 16.42 | -5,460.76 | 0.0651 | -- | 50.39 | -28.62 | -11.43 | -- | 80.73 | -- |
| Astena Holdings Co Ltd | 53.39bn | 2.09bn | 20.25bn | 1.40k | 9.39 | 0.6851 | 4.40 | 0.3792 | 52.62 | 52.62 | 1,341.82 | 721.11 | 0.7976 | 3.29 | 2.69 | 38,024,920.00 | 3.12 | 2.49 | 5.76 | 4.44 | 34.11 | 25.33 | 3.91 | 2.32 | 0.879 | 391.65 | 0.349 | 44.92 | 4.73 | -2.85 | 100.61 | -3.85 | 38.54 | 11.38 |
| StemRIM Inc | 0.00 | -2.02bn | 21.96bn | 44.00 | -- | 2.47 | -- | -- | -32.98 | -32.98 | 0.00 | 144.57 | 0.00 | -- | -- | 0.00 | -20.44 | -8.34 | -20.74 | -8.49 | -- | -- | -- | -68.74 | 131.03 | -11,344.72 | 0.00 | -- | -100.00 | -- | -1,301.17 | -- | -4.35 | -- |
| Fuso Pharmaceutical Industries Ltd | 57.72bn | 2.20bn | 24.64bn | 1.31k | 10.13 | 0.5876 | 5.50 | 0.4269 | 257.39 | 257.39 | 6,774.96 | 4,436.49 | 0.7581 | 3.07 | 2.33 | 44,163,730.00 | 2.89 | 1.91 | 4.97 | 3.09 | 26.58 | 26.92 | 3.81 | 2.69 | 0.9406 | 50.75 | 0.267 | 41.10 | 8.61 | 3.76 | -14.21 | 9.02 | 9.13 | -2.64 |
| Daito Pharmaceutical Co Ltd | 47.40bn | 3.23bn | 33.15bn | 1.07k | 10.42 | 0.6352 | 4.83 | 0.6995 | 207.36 | 207.36 | 3,045.21 | 3,400.43 | 0.6178 | 1.86 | 2.76 | 44,294,390.00 | 3.90 | 6.27 | 5.08 | 8.24 | 20.28 | 22.65 | 6.32 | 8.47 | 1.29 | -- | 0.1891 | 19.59 | 3.98 | 2.66 | -8.47 | -1.27 | 11.37 | 11.67 |
| Fuji Pharma Co Ltd | 46.14bn | 6.15bn | 35.22bn | 1.62k | 5.63 | 0.7594 | 3.58 | 0.7635 | 252.85 | 252.85 | 1,898.01 | 1,873.95 | 0.5263 | 1.51 | 3.04 | -- | 7.01 | 4.64 | 11.20 | 6.63 | 38.68 | 41.29 | 13.33 | 8.83 | 0.6834 | -- | 0.391 | 26.14 | 12.84 | 4.93 | 78.98 | 15.73 | 5.89 | 7.94 |
| Cuorips Inc | 19.22m | -770.78m | 45.60bn | 59.00 | -- | 8.15 | -- | 2,372.14 | -102.64 | -102.64 | 2.59 | 696.57 | 0.0032 | 0.83 | 11.65 | 325,813.60 | -12.67 | -- | -13.03 | -- | 56.90 | -- | -4,011.54 | -- | 36.15 | -14.12 | 0.00 | -- | -39.65 | -- | -39.84 | -- | -- | -- |
| Seikagaku Corp | 38.36bn | 2.02bn | 46.42bn | 988.00 | 22.12 | 0.5923 | 11.98 | 1.21 | 36.93 | 36.93 | 703.07 | 1,379.48 | 0.4679 | 1.93 | 4.88 | 38,827,940.00 | 2.46 | 0.4261 | 2.66 | 0.4678 | 47.98 | 54.18 | 5.25 | 0.9814 | 4.53 | -- | 0.0051 | 465.78 | 8.24 | 4.99 | -2.24 | -0.5224 | 30.28 | 0.00 |
Data as of Nov 22 2024. Currency figures normalised to Fuji Pharma Co Ltd's reporting currency: Japanese Yen JPY
9.33%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 05 Aug 2024 | 548.00k | 2.21% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 514.56k | 2.08% |
| Dimensional Fund Advisors LPas of 07 Nov 2024 | 363.49k | 1.47% |
| Nikko Asset Management Co., Ltd.as of 08 Nov 2024 | 271.50k | 1.10% |
| Daiwa Asset Management Co. Ltd.as of 31 Oct 2024 | 204.30k | 0.83% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 103.60k | 0.42% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 07 Nov 2024 | 93.40k | 0.38% |
| Dimensional Fund Advisors Ltd.as of 07 Nov 2024 | 77.38k | 0.31% |
| Mellon Investments Corp.as of 07 Nov 2024 | 74.10k | 0.30% |
| Chibagin Asset Management Co. Ltd.as of 22 Jan 2024 | 59.30k | 0.24% |
More ▼
Data from 11 Mar 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
